By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immusol, Inc. 

10790 Roselle Street

San Diego  California  92121  U.S.A.
Phone: 858-824-1100 Fax: 858-824-1112



Drug Discovery

Company News
Immusol, Inc. Changes Name to ItherX, Names New CEO 12/17/2007 7:19:25 AM
BioInvent And Immusol, Inc. To Collaborate On Antibody Therapeutic For Macular Degeneration 4/3/2006 5:23:03 PM
Immusol, Inc. Announces An Exclusive Worldwide License Agreement With Baylor College of Medicine For A Novel Cancer Therapy 2/1/2006 2:54:25 PM
Immusol, Inc. Announces Appointment Of Chief Financial Officer10/19/2005 5:10:51 PM
Immusol, Inc. Announces Two Management Appointments10/19/2005 5:09:45 PM
Clark F. Springgate, M.D., Ph.D. Named Immusol, Inc. Vice President Of Clinical And Regulatory10/19/2005 5:09:43 PM
Former Genentech (DNA) Veteran Joins Immusol, Inc. To Advance Therapeutic Development Efforts10/19/2005 5:09:43 PM
Immusol, Inc. Announces Research Collaboration With Peking University To Develop Therapeuic Compounds10/19/2005 5:09:11 PM
Immusol, Inc. Announces License Agreement For Wet AMD Target With The University of Kentucky10/19/2005 5:09:09 PM
Immusol, Inc. Announces Collaboration With Novartis Corporation (NVS)10/19/2005 5:09:09 PM